Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
Ma, Brigette B Y, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex Y C, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, K C Allen, Lo, Y M Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony T C
Published in Journal of clinical oncology (10.05.2018)
Published in Journal of clinical oncology (10.05.2018)
Get full text
Journal Article
Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Horn, Leora, Infante, Jeffrey R, Reckamp, Karen L, Blumenschein, George R, Leal, Ticiana A, Waqar, Saiama N, Gitlitz, Barbara J, Sanborn, Rachel E, Whisenant, Jennifer G, Du, Liping, Neal, Joel W, Gockerman, Jon P, Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J, Holzhausen, Allison, Lovly, Christine M, Wakelee, Heather A
Published in Clinical cancer research (15.06.2018)
Published in Clinical cancer research (15.06.2018)
Get full text
Journal Article
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial
Lee, Jay M, Vallières, Eric, Ding, Beiying, Johnson, Ann, Bhagwakar, Jan, Rashidi, Sanam, Zhu, Qian Cindy, Gitlitz, Barbara J, Weksler, Benny, Costas, Kimberly, Altorki, Nasser
Published in The Journal of thoracic and cardiovascular surgery (01.09.2023)
Published in The Journal of thoracic and cardiovascular surgery (01.09.2023)
Get full text
Journal Article
Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Ou, Sai-Hong Ignatius, Lee, Thomas K, Young, Lauren, Fernandez-Rocha, Maria Y, Pavlick, Dean, Schrock, Alexa B, Zhu, Viola W, Milliken, Jeffrey, Ali, Siraj M, Gitlitz, Barbara J
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2017)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2017)
Get full text
Journal Article
Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer
SEQUIST, Lecia V, BESSE, Benjamin, ANANTHAKRISHNAN, Revathi, QUINN, Susan, SORIA, Jean-Charles, LYNCH, Thomas J, MILLER, Vincent A, WONG, Kwok K, GITLITZ, Barbara, EATON, Keith, ZACHARCHUK, Charles, FREYMAN, Amy, POWELL, Christine
Published in Journal of clinical oncology (20.06.2010)
Published in Journal of clinical oncology (20.06.2010)
Get full text
Journal Article
HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib
Ou, Sai-Hong Ignatius, Schrock, Alexa B., Bocharov, Eduard V., Klempner, Samuel J., Haddad, Carolina Kawamura, Steinecker, Gary, Johnson, Melissa, Gitlitz, Barbara J., Chung, Jon, Campregher, Paulo V., Ross, Jeffrey S., Stephens, Philip J., Miller, Vincent A., Suh, James H., Ali, Siraj M., Velcheti, Vamsidhar
Published in Journal of thoracic oncology (01.03.2017)
Published in Journal of thoracic oncology (01.03.2017)
Get full text
Journal Article
Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer
Ramalingam, Suresh S, Maitland, Michael L, Frankel, Paul, Argiris, Athanassios E, Koczywas, Marianna, Gitlitz, Barbara, Thomas, Sachdev, Espinoza-Delgado, Igor, Vokes, Everett E, Gandara, David R, Belani, Chandra P
Published in Journal of clinical oncology (01.01.2010)
Published in Journal of clinical oncology (01.01.2010)
Get full text
Journal Article
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Vannini, Ivan, Wise, Petra M, Challagundla, Kishore B, Plousiou, Meropi, Raffini, Mirco, Bandini, Erika, Fanini, Francesca, Paliaga, Giorgia, Crawford, Melissa, Ferracin, Manuela, Ivan, Cristina, Fabris, Linda, Davuluri, Ramana V, Guo, Zhiyi, Cortez, Maria Angelica, Zhang, Xinna, Chen, Lu, Zhang, Shuxing, Fernandez-Cymering, Cecilia, Han, Leng, Carloni, Silvia, Salvi, Samanta, Ling, Hui, Murtadha, Mariam, Neviani, Paolo, Gitlitz, Barbara J, Laird-Offringa, Ite A, Nana-Sinkam, Patrick, Negrini, Massimo, Liang, Han, Amadori, Dino, Cimmino, Amelia, Calin, George A, Fabbri, Muller
Published in Nature communications (27.11.2017)
Published in Nature communications (27.11.2017)
Get full text
Journal Article
Improved efficacy of pembrolizumab combined with soluble EphB4-albumin in HPV-negative EphrinB2 positive head neck squamous cell carcinoma
Jackovich, Alexandra, Gitlitz, Barbara J., Tiu-lim, Justin Wayne Wong, Duddalwar, Vinay, King, Kevin George, El-Khoueiry, Anthony B., Thomas, Jacob Stephen, Tsao-Wei, Denice, Quinn, David I., Gill, Parkash S., Nieva, Jorge J.
Published in Oncotarget (10.07.2024)
Published in Oncotarget (10.07.2024)
Get full text
Journal Article
Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial
Ferris, Robert L, Saba, Nabil F, Gitlitz, Barbara J, Haddad, Robert, Sukari, Ammar, Neupane, Prakash, Morris, John C, Misiukiewicz, Krzysztof, Bauman, Julie E, Fenton, Moon, Jimeno, Antonio, Adkins, Douglas R, Schneider, Charles J, Sacco, Assuntina G, Shirai, Keisuke, Bowles, Daniel W, Gibson, Michael, Nwizu, Tobenna, Gottardo, Raphael, Manjarrez, Kristi L, Dietsch, Gregory N, Bryan, James Kyle, Hershberg, Robert M, Cohen, Ezra E W
Published in JAMA oncology (01.11.2018)
Published in JAMA oncology (01.11.2018)
Get more information
Journal Article
I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK -positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib
Ou, Sai-Hong Ignatius, Greenbowe, Joel, Khan, Ziad U, Azada, Michele C, Ross, Jeffrey S, Stevens, Phil J, Ali, Siraj M, Miller, Vincent A, Gitlitz, Barbara
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2015)
Published in Lung cancer (Amsterdam, Netherlands) (01.05.2015)
Get full text
Journal Article
Phase II Trial of Cabozantinib Plus Erlotinib in Patients With Advanced Epidermal Growth Factor Receptor ( EGFR )-Mutant Non-small Cell Lung Cancer With Progressive Disease on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy: A California Cancer Consortium Phase II Trial (NCI 9303)
Reckamp, Karen L, Frankel, Paul H, Ruel, Nora, Mack, Philip C, Gitlitz, Barbara J, Li, Tianhong, Koczywas, Marianna, Gadgeel, Shirish M, Cristea, Mihaela C, Belani, Chandra P, Newman, Edward M, Gandara, David R, Lara, Jr, Primo N
Published in Frontiers in oncology (11.03.2019)
Published in Frontiers in oncology (11.03.2019)
Get full text
Journal Article
Important Surgical and Clinical End Points in Neoadjuvant Immunotherapy Trials in Resectable NSCLC
Lee, Jay M., Kim, Anthony W., Marjanski, Tomasz, Falcoz, Pierre-Emmanuel, Tsuboi, Masahiro, Wu, Yi-Long, Sun, Shawn W., Gitlitz, Barbara J.
Published in JTO clinical and research reports (01.10.2021)
Published in JTO clinical and research reports (01.10.2021)
Get full text
Journal Article
Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
DAUD, Adil I, KRISHNAMURTHI, Smitha S, BARDY-BOUXIN, Nathalie, HSYU, Poe-Hirr, LEIP, Eric, TURNBULL, Kathleen, ZACHARCHUK, Charles, MESSERSMITH, Wells A, SALEH, Mansoor N, GITLITZ, Barbara J, BORAD, Mitesh J, GOLD, Philip J, CHIOREAN, Elena G, SPRINGETT, Gregory M, ABBAS, Richat, AGARWAL, Shefali
Published in Clinical cancer research (15.02.2012)
Published in Clinical cancer research (15.02.2012)
Get full text
Journal Article
A Randomized, Placebo-Controlled, Multicenter, Biomarker-Selected, Phase 2 Study of Apricoxib in Combination with Erlotinib in Patients with Advanced Non–Small-Cell Lung Cancer
Gitlitz, Barbara J., Bernstein, Eric, Santos, Edgardo S., Otterson, Greg A., Milne, Ginger, Syto, Mary, Burrows, Francis, Zaknoen, Sara
Published in Journal of thoracic oncology (01.04.2014)
Published in Journal of thoracic oncology (01.04.2014)
Get full text
Journal Article
Phase II Study of Belinostat (PXD101), a Histone Deacetylase Inhibitor, for Second Line Therapy of Advanced Malignant Pleural Mesothelioma
Ramalingam, Suresh S., Belani, Chandra P., Ruel, Christopher, Frankel, Paul, Gitlitz, Barbara, Koczywas, Marianna, Espinoza-Delgado, Igor, Gandara, David
Published in Journal of thoracic oncology (01.01.2009)
Published in Journal of thoracic oncology (01.01.2009)
Get full text
Journal Article
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
ZISMAN, Amnon, PANTUCK, Allan J, DOREY, Fredrick, SAID, Jonathan W, SHVARTS, Oleg, QUINTANA, Deanna, GITLITZ, Barbara J, DEKERNION, Jean B, FIGLIN, Robert A, BELLDEGRUN, Arie S
Published in Journal of clinical oncology (15.03.2001)
Published in Journal of clinical oncology (15.03.2001)
Get full text
Journal Article
Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
Campbell, Nicholas P, Kunnavakkam, Rangesh, Leighl, Natasha, Vincent, Mark D, Gandara, David R, Koczywas, Marianna, Gitlitz, Barbara J, Agamah, Edem, Thomas, Sachdev P, Stadler, Walter M, Vokes, Everett E, Kindler, Hedy L
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Published in Lung cancer (Amsterdam, Netherlands) (01.10.2012)
Get full text
Journal Article
Assessing Pathologic Response in Resected Lung Cancers: Current Standards, Proposal for a Novel Pathologic Response Calculator Tool, and Challenges in Practice
Saqi, Anjali, Leslie, Kevin O., Moreira, Andre L., Lantuejoul, Sylvie, Shu, Catherine Ann, Rizvi, Naiyer A., Sonett, Joshua R., Tajima, Kosei, Sun, Shawn W., Gitlitz, Barbara J., Colby, Thomas V.
Published in JTO clinical and research reports (01.05.2022)
Published in JTO clinical and research reports (01.05.2022)
Get full text
Journal Article